CHU Lyon, Unité de Pharmacoépidémiologie, Service de Neurologie, Hôpital Pierre Wertheimer, 59 Boulevard Pinel, Bron, France.
Respir Med. 2009 Sep;103(9):1366-75. doi: 10.1016/j.rmed.2009.03.010. Epub 2009 Apr 24.
Patient adherence to recommended use of ICS is questionable in asthma, with irregular use or interruptions occurring frequently. Factors explaining discontinuation of controller therapy could orientate interventions. The characteristics of patients with interruptions of inhaled corticosteroids (ICSs), intentional or accidental, were investigated.
Asthma patients regularly prescribed ICS by GPs (Cegedim network) were included. Patients' characteristics and behaviours toward ICS (accidental/intentional interruptions, less frequent use of ICS and change in dosing) were identified from self-report questionnaires, and linked to data prescription database. Interrelations between declared behaviours toward ICS were studied with a Multiple Component Analysis (MCA) and the correlates of ICS interruptions were identified.
During the past 3 months, 31.6% of 204 patients (mean age: 53.8 years, females: 59.3%) intentionally interrupted ICS when feeling better, 25.4% forgot ICS and 18.3% deliberately changed the doses. A quarter of patients considered constant use of respiratory medicines as unhealthy. MCA revealed that intentional, accidental interruptions and less frequent use of ICS were closely correlated. Risk of intentional interruption was increased when patients considered constant use of respiratory therapy to be unhealthy (OR=3.36, 95%CI=[1.47-7.66]). Conversely, risk was significantly lower when ICS was associated or combined with another controller (OR=0.24, 95%CI=[0.08-0.73]), compared to ICS in monotherapy. Less frequent interruptions were observed in patients older than 65 (OR=0.35, 95%CI=[0.13-0.89]).
Our study suggests that discontinuation of use of controllers is associated with other inadequate behaviours or beliefs about inhaled controllers. Efforts should be targeted at patients' perceptions and behaviours toward controller therapy.
在哮喘中,患者对推荐使用吸入性皮质类固醇(ICS)的依从性值得怀疑,经常出现不规则使用或中断。解释停止使用控制器治疗的因素可以为干预提供方向。本研究旨在调查因意外或故意中断吸入皮质激素(ICS)的患者特征。
我们纳入了由全科医生(Cegedim 网络)定期处方 ICS 的哮喘患者。从自我报告问卷中确定患者的特征和 ICS 使用行为(意外/故意中断、ICS 使用频率降低和剂量改变),并将这些数据与处方数据库相关联。使用多成分分析(MCA)研究了声明的 ICS 使用行为之间的相互关系,并确定了 ICS 中断的相关因素。
在过去 3 个月中,31.6%(204 例患者中的 64 例)在感觉好转时故意中断 ICS,25.4%的患者忘记使用 ICS,18.3%的患者故意改变剂量。四分之一的患者认为持续使用呼吸药物是不健康的。MCA 显示,故意、意外中断和 ICS 使用频率降低密切相关。当患者认为持续使用呼吸治疗是不健康的时,故意中断的风险增加(OR=3.36,95%CI=[1.47-7.66])。相反,与 ICS 单药治疗相比,ICS 与其他控制器联合或联合使用时(OR=0.24,95%CI=[0.08-0.73]),中断的风险显著降低。年龄大于 65 岁的患者中断频率较低(OR=0.35,95%CI=[0.13-0.89])。
我们的研究表明,停止使用控制器与对吸入性控制器的其他不当行为或信念有关。应针对患者对控制器治疗的看法和行为进行干预。